SF3B1 is mutated in the early stage of myeloid malignancies, whereas SF3B1 mutations in chronic lymphocytic leukemia (CLL) are most commonly subclonal and enriched in more advanced and aggressive disease (22, 23). The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.